Search Results - "Manzyuk, L V"

Tactics for minimizing risk of increasing estradiol against the background of aromatase inhibitors in combination with gonadotropin releasing hormone agonists in adjuvant therapy for breast cancer in premenopausal patients. Pilot study results by I. B. Kononenko, A. V. Snegovoi, L. V. Manzyuk, E. I. Kovalenko, V. Yu. Selchuk

“…Aromatase inhibitor (AI) combined with Gonadotropin-releasing hormone agonist (GnRH-a) have been recognized as an effective approach to adjuvant…”
Get full text

Adverse effects of adjuvant endocrine therapy by E. I. Kovalenko, I. B. Kononenko, A. V. Snegovoi, O. P. Grebennikova, L. V. Manzyuk

“…Hormonal therapy is a highly effective and well tolerable treatment of hormone-responsive breast cancer. However, it has some side effects that can affect…”
Get full text

Importance of evaluation of ovarian function in women with breast cancer when using endocrinotherapy by I. B. Kononenko, A. V. Snegovoi, E. I. Kovalenko, L. V. Manzyuk, V. Yu. Selchuk

“…The randomized clinical trials showed the effectiveness of the addition of ovarian suppression to tamoxifen or to aromatase inhibitors after adjuvant…”
Get full text

Results of the use of ramucirumab in combination with paclitaxel or ramucirumab monotherapy as the second line treatment in patients with disseminated HER2-negative gastric or cardioesophageal junction adenocarcinoma: experience of N.N. Blokhin russian cancer research center of the ministry of health of Russia by N. S. Besova, T. A. Titova, E. V. Trusilova, V. A. Gorbunova, A. A. Tryakin, O. O. Gordeeva, A. A. Rumyantsev, R. Yu. Nasyrova, L. G. Zhukova, A. V. Snegovoy, E. V. Artamonova, L. V. Manzyuk, A. A. Fedenko

“…Background. Working out of the second line chemotherapy of advanced gastric adenocarcinoma is a promising approach to cancer therapy. Ramucirumab, an…”
Get full text

Analysis of the −238(G/A)TNF polymorphism in breast-cancer patients by Malivanova, T. F., Skoromyslova, E. V., Yurchenko, V. A., Kononenko, I. B., Manzyuk, L. V., Mazurenko, N. N.

“…Tumor-necrosis factor (TNF) is an inflammatory cytokine that is involved in pathogenesis of different malignancies. The single-nucleotide polymorphism…”
Get full text

Antitumor activity of specific immunotherapy with mucin containing CA 125 antigen in mice with CaO 1 ovarian carcinoma by Amandzholov, B S, Sitdikova, S M, Lebedin, Y S, Chukanov, S V, Toptygin, A Y, Manzyuk, L V, Donenko, F V

“…Experiments in CBA mice with transplanted CaO 1 ovarian carcinoma possessing common antigenic determinants with human ovarian carcinoma showed that specific…”
Get full text

Immunotoxicological characteristics of preparations based on carcinoembryonic antigen and mucin containing CA 125 antigen by Sitdikova, S M, Amandzholov, B S, Sel'chuk, V Y, Kormosh, N G, Laktionov, K P, Lebedin, Y S, Chukanov, S V, Toptygin, A Y, Manzyuk, L V, Donenko, F V

“…Experiments on male hybrid mice demonstrated that specific immunotherapy with preparations based on carcinoembryonal antigen and mucin containing CA 125…”
Get full text

Role of ganaton in antiemetic therapy. New treatment capacities by A. V. Snegovoy, L. V. Manzyuk

“…The practical introduction of new effective drugs for the prevention and treatment of nausea and vomiting is one of the important constitu- ents of maintenance…”
Get full text

Efficacy of Heptral® in the treatment of hepatic toxicity induced by cytostatic chemotherapy by A. V. Snegovoy, L. V. Manzyuk

“…The efficacy of Heptral® (ademethionine) was evaluated in the treatment of chemotherapy-induced hepatotoxicity in 19 patients with various malignancies…”
Get full text

HER-2-positive metastatic breast cancer: new possibilities for therapy by E. V. Artamonova, L. V. Manzyuk

“…This article is devoted to modern approaches in HER-2-positive metastatic breast cancer therapy. Recently treatment algorithm for this type of cancer included…”
Get full text

The optimization of second-line therapy for metastatic colorectal cancer: new targeted therapy options by Artamonova, E.V., Manzyuk, L.V.

“…Advances in the treatment of metastatic colorectal cancer (mCRC) during the past years, largely associated with the wide use of targeted agents and effective…”
Get full text

Eribulin in the treatment for metastatic breast cancer by Manzyuk, L V, Kovalenko, E I, Artamonova, E

“…Eribulin is a novel antimicrotubule drug, which is approved in the second line treatment of advanced breast cancer in patients who received anthracyclines and…”
Get more information

New possibilities of chemotherapy for anthracyclineand/or taxane-resistant breast cancer by E V Artamonova, L V Manzyuk

“…Patients with metastatic breast cancer previously treated with anthracycline chemotherapy. Effective treatment options for patients with metastatic breast…”
Get full text

Platinum preparations in the treatment of trophoblastic tumors by I. V. Markina, B. O. Toloknov, L. V. Manzyuk, E. E. Makhova, N. G. Kormosh

“…The N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, has developed and used new polychemotherapy regimens including platinum…”
Get full text

Time course of changes in bone resorption markers during pamidronate therapy in breast cancer patients with bone metastases by A. D. Petrova, M. B. Stenina, L. V. Manzyuk, N. V. Lyubimova, S. A. Tyulyandin

“…The paper gives the results of evaluating the time course of changes in the level of bone resorption markers (S-CTx and dPir) in pami- dronate-treated patients…”
Get full text

Analysis of the -238(G/A)TNF polymorphism in breast cancer patients by Malivanova, T F, Skoromyslova, E V, Yurchenko, V A, Kononenko, I V, Manzyuk, L V, Mazurenko, N N

“…TNF is an inflammatory cytokine that involved in pathogenesis of different malignancies. Promoter single nucleotide polymorphism -238(G/A)TNF (rs361525) is…”
Get more information

Interactions between natural autoantibodies to tumor-associated human ovarian cancer antigen and murine ovarian cancer cells CaO-1 by Amandzholov, B. S., Lebedin, Yu. S., Chukanov, S. V., Toptygin, A. Yu, Sitdikova, S. M., Moroz, L. L., Manyuk, L. V., Donenko, F. V.

“…The interactions between tumor cells and autoantibodies to tumor-associated human ovarian cancer antigen isolated from the plasma of a non-cancer patient are…”
Get full text

Kapetsitabin v terapiiantratsiklin- i taksanrezistentnogoraka molochnoy zhelezy by E I Kovalenko, E V Artamonova, E F Satirova, L V Manzyuk

Get full text

Original'naya kombinatsiyaFtorafur® + vinorelbinv lechenii raka molochnoy zhelezy:pervye rezul'taty by L V Manzyuk, E V Artamonova, E F Satirova, E S Alatortseva

Get full text

Ftorafur - pervyy peroral'nyy ftorpirimidin v terapii metastaticheskogo kolorektal'nogo raka by L V Manzyuk, N I Perevodchikova, V A Gorbunova, E V Artamonova, L E Rotobel'skaya, N A Abramova

“…В течение длительного периода времени стандартным режимом при метастатическом раке толстой кишки являлась комбинация 5-фторурацила и лейковорина, эффективность…”
Get full text